Diabetes, prediabetes and cancer mortality
(2010) In Diabetologia 53(9). p.1867-1876- Abstract
- Aims/hypothesis We aimed to investigate the risk of cancer mortality in relation to the glucose tolerance status classified according to the 2 h OGTT. Methods Data from 17 European population-based or occupational cohorts involved in the DECODE study comprising 26,460 men and 18,195 women aged 25-90 years were collaboratively analysed. The cohorts were recruited between 1966 and 2004 and followed for 5.9 to 36.8 years. Cox proportional hazards analysis with adjustment for cohort, age, BMI, total cholesterol, blood pressure and smoking status was used to estimate HRs for cancer mortality. Results Compared with people in the normal glucose category, multivariable adjusted HRs (95% CI) for cancer mortality were 1.13 (1.00, 1.28), 1.27 (1.02,... (More)
- Aims/hypothesis We aimed to investigate the risk of cancer mortality in relation to the glucose tolerance status classified according to the 2 h OGTT. Methods Data from 17 European population-based or occupational cohorts involved in the DECODE study comprising 26,460 men and 18,195 women aged 25-90 years were collaboratively analysed. The cohorts were recruited between 1966 and 2004 and followed for 5.9 to 36.8 years. Cox proportional hazards analysis with adjustment for cohort, age, BMI, total cholesterol, blood pressure and smoking status was used to estimate HRs for cancer mortality. Results Compared with people in the normal glucose category, multivariable adjusted HRs (95% CI) for cancer mortality were 1.13 (1.00, 1.28), 1.27 (1.02, 1.57) and 1.71 (1.35, 2.17) in men with prediabetes, previously undiagnosed diabetes and known diabetes, respectively; in women they were 1.11 (0.94, 1.30), 1.31 (1.00, 1.70) and 1.43 (1.01, 2.02), respectively. Significant increases in deaths from cancer of the stomach, colon-rectum and liver in men with prediabetes and diabetes, and deaths from cancers of the liver and pancreas in women with diabetes were also observed. In individuals without known diabetes, the HR (95% CI) for cancer mortality corresponding to a one standard deviation increase in fasting plasma glucose was 1.06 (1.02, 1.09) and in 2 h plasma glucose was 1.07 (1.03, 1.11). Conclusions/interpretation Diabetes and prediabetes were associated with an increased risk of cancer death, particularly death from liver cancer. Mortality from all cancers rose linearly with increasing glucose concentrations. (Less)
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/1673893
- author
- organization
- publishing date
- 2010
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Mortality, Cancer, Diabetes
- in
- Diabetologia
- volume
- 53
- issue
- 9
- pages
- 1867 - 1876
- publisher
- Springer
- external identifiers
-
- wos:000281012200009
- scopus:77955560604
- pmid:20490448
- ISSN
- 1432-0428
- DOI
- 10.1007/s00125-010-1796-7
- language
- English
- LU publication?
- yes
- id
- 990efd92-dcdf-4fe3-8ada-2c3444c6c091 (old id 1673893)
- date added to LUP
- 2016-04-01 09:51:23
- date last changed
- 2022-04-27 08:07:31
@article{990efd92-dcdf-4fe3-8ada-2c3444c6c091,
abstract = {{Aims/hypothesis We aimed to investigate the risk of cancer mortality in relation to the glucose tolerance status classified according to the 2 h OGTT. Methods Data from 17 European population-based or occupational cohorts involved in the DECODE study comprising 26,460 men and 18,195 women aged 25-90 years were collaboratively analysed. The cohorts were recruited between 1966 and 2004 and followed for 5.9 to 36.8 years. Cox proportional hazards analysis with adjustment for cohort, age, BMI, total cholesterol, blood pressure and smoking status was used to estimate HRs for cancer mortality. Results Compared with people in the normal glucose category, multivariable adjusted HRs (95% CI) for cancer mortality were 1.13 (1.00, 1.28), 1.27 (1.02, 1.57) and 1.71 (1.35, 2.17) in men with prediabetes, previously undiagnosed diabetes and known diabetes, respectively; in women they were 1.11 (0.94, 1.30), 1.31 (1.00, 1.70) and 1.43 (1.01, 2.02), respectively. Significant increases in deaths from cancer of the stomach, colon-rectum and liver in men with prediabetes and diabetes, and deaths from cancers of the liver and pancreas in women with diabetes were also observed. In individuals without known diabetes, the HR (95% CI) for cancer mortality corresponding to a one standard deviation increase in fasting plasma glucose was 1.06 (1.02, 1.09) and in 2 h plasma glucose was 1.07 (1.03, 1.11). Conclusions/interpretation Diabetes and prediabetes were associated with an increased risk of cancer death, particularly death from liver cancer. Mortality from all cancers rose linearly with increasing glucose concentrations.}},
author = {{Zhou, X. H. and Qiao, Q. and Zethelius, B. and Pyorala, K. and Soderberg, S. and Pajak, A. and Stehouwer, C. D. A. and Heine, R. J. and Jousilahti, P. and Ruotolo, G. and Nilsson, Peter and Calori, G. and Tuomilehto, J.}},
issn = {{1432-0428}},
keywords = {{Mortality; Cancer; Diabetes}},
language = {{eng}},
number = {{9}},
pages = {{1867--1876}},
publisher = {{Springer}},
series = {{Diabetologia}},
title = {{Diabetes, prediabetes and cancer mortality}},
url = {{http://dx.doi.org/10.1007/s00125-010-1796-7}},
doi = {{10.1007/s00125-010-1796-7}},
volume = {{53}},
year = {{2010}},
}